Hyderabad Lithotriplsy Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.99 M
as on 17-07-2024
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.44 Cr
as on 17-07-2024
- Revenue 551.48%
(FY 2023)
- Profit 228.20%
(FY 2023)
- Ebitda -4.74%
(FY 2023)
- Net Worth 18.53%
(FY 2023)
- Total Assets 22.99%
(FY 2023)
About Hyderabad Lithotriplsy Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.99 M.
The company currently has active open charges totaling ₹2.44 Cr.
Padmaja Aravabhumi and Venkata Kumar serve as directors at the Company.
- CIN/LLPIN
U10200TG1994PTC018570
- Company No.
018570
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, A.P., Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hyderabad Lithotriplsy Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Kumar  | Whole-Time Director | 30-Jun-2006 | Current |
| Padmaja Aravabhumi | Director | 01-Apr-2015 | Current |
Financial Performance and Corporate Structure Insights of Hyderabad Lithotriplsy Centre.
Hyderabad Lithotriplsy Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 551.48% increase. The company also saw a substantial improvement in profitability, with a 228.2% increase in profit. The company's net worth Soared by an impressive increase of 18.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hyderabad Lithotriplsy Centre?
In 2023, Hyderabad Lithotriplsy Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hyderabad Institute Of Urology Private LimitedActive 21 years 10 monthsPadmaja Aravabhumi and Venkata Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 19 Jun 2009 | ₹0.63 M | Open |
Bank Of Baroda Creation Date: 27 Apr 2007 | ₹1.23 M | Open |
Uti Bank Ltd. Creation Date: 26 Jun 1990 | ₹2.00 Cr | Open |
How Many Employees Work at Hyderabad Lithotriplsy Centre?
Unlock and access historical data on people associated with Hyderabad Lithotriplsy Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyderabad Lithotriplsy Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyderabad Lithotriplsy Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
